Medincell SA (MEDCL) — Capital Reinvestment Ratio

Latest as of September 2024: 0.01x

Medincell SA (MEDCL) has a Capital Reinvestment Ratio of 0.01x as of September 2024, meaning it reinvests 0% of its operating cash flow (€21.56 Million) in capital expenditures (€195.00K). See Medincell SA balance sheet quality to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.01x
Capex / Operating Cash Flow

Operating Cash Flow

€21.56 Million
EUR

Capital Expenditures

€195.00K
EUR

Data as of

Sep 2024
Most recent filing

Medincell SA Capital Reinvestment Ratio (2016–2025)

This chart tracks Medincell SA's Capital Reinvestment Ratio across 2 annual periods. Check Medincell SA (MEDCL) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Medincell SA (2016–2025)

Year-by-year Capital Reinvestment Ratio for Medincell SA from 2016 to 2025. For live market cap and broader valuation context, see MEDCL stock market capitalisation.

Year Reinvestment Ratio Operating CF (EUR) Capital Expenditures YoY Change
2025 0.09x €19.46 Million €1.66 Million ▼ -99.5%
2016 17.12x €68.00K €1.16 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow